Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

http://www.wikidata.org/entity/Q36893677

about

Prenatal lead levels, plasma amyloid β levels, and gene expression in young adulthood Biological markers of amyloid beta-related mechanisms in Alzheimer's disease Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics Body fluid biomarkers in Alzheimer's disease Cerebrospinal fluid and blood biomarkers in Alzheimer's disease Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.High-throughput 3D whole-brain quantitative histopathology in rodents.HSV-1 and Alzheimer's disease: more than a hypothesis.Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO mice Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease Circulating biomarkers that predict incident dementia.Blood-based biomarkers of Alzheimer's disease: challenging but feasible Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons Effects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulations Soluble amyloid-β levels and late-life depression Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Therapy for Alzheimer's Disease: How Effective are Current Treatments?Plasma ß-amyloid and cognitive decline.Biomarkers of Alzheimer's disease: from central nervous system to periphery?A summary risk score for the prediction of Alzheimer disease in elderly persons Biomarkers of the dementia.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study.Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study Epidemiology of Alzheimer disease.Nutrient intake and plasma β-amyloid.Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.Change in plasma Aß peptides and onset of dementia in adults with Down syndrome.Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD.Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease.The demographic and medical correlates of plasma aβ40 and aβ42 Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice

P2860

Q24288814-BE24C074-CEDC-462F-B990-FD3B0DD30327 Q24622136-B04F7954-79A9-4E3D-9B89-A3401551353C Q26784569-53D9F71C-B388-4D0F-8309-CA0009B7254C Q26822002-7B6948EE-8F85-457D-AEBB-A8D0DBDA9FD8 Q26830098-7F0F0B0E-2F88-49ED-A41F-614622F7D4C6 Q27023758-52EC7404-4CA7-4A39-A6F9-7D2E9E0B7971 Q27310276-7C66ECFE-20B5-4966-BF06-0797C89B6630 Q27349467-047AA287-5C0C-4B0E-959F-E780E3535332 Q27692651-49EB4B7A-CB2F-443E-B538-05BE16FC609B Q28740764-134602F3-B98B-49EE-926C-945BF4B8D274 Q30315907-995BD61B-C7F3-4D82-BBCF-4A02F699C89A Q30473360-A416BED2-8111-4EB9-847D-0F5B9676895B Q33591314-95995FC3-9291-4C41-AC04-35D1E61DC9DA Q33752058-03B34E2E-84AD-4862-B308-5B1261CF5EE7 Q33824444-11155F7B-BED6-419C-AF62-62BC19B09ED9 Q33828173-99865A8F-AB14-4905-B040-74256F0A0C98 Q33832139-390D3131-D0AD-406D-9143-00508E6F9887 Q33868997-EE9E41F3-AFA3-4136-B70A-144C7EE0805A Q33933220-41309E8D-ED4C-465D-AC37-14AE273E20DB Q34201730-2796D674-B027-41A2-99F4-DDF6DC0F69B2 Q34292024-34B66AB1-989A-4CF9-86DF-52B4A99F8B5D Q34409349-BF6B4495-66F5-44FE-AF76-E7617F9A6245 Q34424794-5A377560-4F5C-422E-8AAD-83E52EAA7306 Q34442605-ACAA4B7E-7875-47F3-9D58-F16A00A24BC6 Q34747831-D9545CA8-7381-4C4E-9EED-5F7FD911BE5A Q35030049-A9A6E661-C287-4CAE-B00E-4423B42F50D9 Q35031724-BF773A25-C443-4BA8-AFC4-A995337DCB32 Q35117068-9C5BEAE9-CED7-488A-968B-4618694F2FC0 Q35118684-A6D446E1-A02B-4282-AEE9-CCCA52661026 Q35601036-9920F250-15FE-4975-BEB2-5318EFF4410C Q35821382-DA737A0A-F68E-4B3B-AEC9-655D514DABDC Q35870513-70B3F556-A690-454B-8442-1781DDECC039 Q35920548-0F69A8A4-ABB9-459E-9AD0-621F88D0FF0B Q36014708-106E2B43-CE81-4888-9E29-086A13F5DD22 Q36037548-CFE7C0CB-093D-433A-9FDD-E461EBBE095A Q36064807-B319A2B8-5146-45D3-BE2B-9A4B31F7C5A4 Q36200059-045ECF21-8F1D-49CB-8071-6499CC053878 Q36265279-B3C22769-D055-4BB1-B81B-139114E3E262 Q36322974-9071AD46-D663-4396-9261-C38FADD20F07 Q36528218-30E29F09-D1CA-495F-AC17-0338CFBA0899

P2860

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

http://www.wikidata.org/entity/Q36893677

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

@en

type

label

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

@en

prefLabel

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

@en

P1433

Q36893677-5F7718AA-34B1-4A5E-BB9E-2CEB425FF0FB

P1476

Q36893677-02528521-0BFB-4BCC-B7B0-B81842D35174

P2093

Q36893677-1590713B-76F6-4819-B06A-5B2EC4036426

Q36893677-22837209-19A4-4F87-BB65-F8B226E9C0C1

Q36893677-3D7D2BB6-6C06-4464-8FE0-6C827DB4F3AD

Q36893677-4CD18A73-4F42-471D-8208-32D5C2EC04CC

Q36893677-8E75652C-6A6E-44BA-8BA7-B5044B12C433

Q36893677-98E4D0AB-0A83-4B17-A1E6-8C0F9234DCD9

Q36893677-DE984223-1B2F-4661-ADCD-6B75627E8682

P2860

Q36893677-0ADD0B77-4B20-4903-BDBE-2B5DE62774A5

Q36893677-13C63FB4-A0FC-47A7-8E73-B9921DA60C85

Q36893677-19327945-4CA4-4842-9AEC-F61F907EC3C6

Q36893677-1FA8A421-C2FB-4AEB-9A61-6E19111644BB

Q36893677-26AE1252-18E3-48B2-A77F-4C1F516109C3

Q36893677-27D100D1-9814-42DC-BF4C-9FC94BB2C690

Q36893677-3567A0DA-B86D-48E9-9825-CD1116396AA8

Q36893677-3C97F985-6463-4630-A194-B48F3C9B7F9D

Q36893677-41993176-3056-43AE-B858-CC46E7A34A39

Q36893677-58F4445B-E38E-4335-BE5F-4C39DA69F5FD

P304

Q36893677-A0DC6DB4-0588-454A-8CC7-BA189640D9A3

P31

Q36893677-8493CDD7-CF7D-4658-A658-4C25181D683B

P356

Q36893677-8EF8E209-3C68-49ED-8F9E-5C7842644C38

P407

Q36893677-3E963752-3DCA-4E96-AF2F-A1D26D18A49E

P433

Q36893677-7618EF6F-DC53-4B58-9A74-4F3E7FD0B68C

P478

Q36893677-A8320CDE-9FF2-47CA-9BA3-7B19757835FD

P50

Q36893677-9201C061-E189-4C16-95A2-760BCE78BA86

P577

Q36893677-FA5F2A88-2B36-428D-8D89-E7ED7E1F666B

P5875

Q36893677-9EF4DE58-B061-4920-9B41-18B7C5E03D07

P698

Q36893677-D5A6BD8C-BD1D-4C4C-890C-A0064E89E599

P921

Q36893677-BEC1D1A8-2C3C-4FBA-AB5A-F5A12C1ECF29

Q36893677-E978DF63-0007-4D17-ACDB-2652CC5BAE68

P932

Q36893677-2CA68125-2E56-423A-8861-4220F1ED22D7

P356

PNAS.0805902105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

@en

P2093

Hide Fukuyama

http://www.w3.org/2001/XMLSchema#string

Howard Andrews

http://www.w3.org/2001/XMLSchema#string

Jeffery Ravetch

http://www.w3.org/2001/XMLSchema#string

Jennifer Manly

http://www.w3.org/2001/XMLSchema#string

Ming X Tang

http://www.w3.org/2001/XMLSchema#string

Nicole Schupf

http://www.w3.org/2001/XMLSchema#string

Pankaj Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

A specific amyloid-beta protein assembly in the brain impairs memory

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease.

Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease

P304

14052-14057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0805902105

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23245335

http://www.w3.org/2001/XMLSchema#string

P698

18779561

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2544577

http://www.w3.org/2001/XMLSchema#string